Smith Darren Charlton bought TLX

March 29, 2026 · Form 4 insider transaction

Smith Darren Charlton bought 1,111 shares of Telix Pharmaceuticals Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction

Acquired (buy-side)

1,111

Price

$0.00

Total value

N/A

InsiderSmith Darren Charlton

Role—

CompanyTelix Pharmaceuticals Limited (TLX)

SecurityOrdinary Shares

Transaction codeM: Option exercise

Transaction dateMarch 29, 2026

Filing dateApril 1, 2026

Shares owned after11,921

OwnershipDirect

10b5-1 planNo

AmendedNo

View the original Form 4 on SEC EDGAR